Holen Sie sich die Stockscreener-App
0.3894
1.54%
0.0059
Cel-Sci Corp. Aktie (CVM) Neueste Nachrichten
CEL-SCI (NYSE:CVM) Earns Sell Rating from Analysts at StockNews.com - Defense World
Personal Finance - Business Wire
Have A Relaxing Holiday Season - MENAFN.COM
Cantex Mine Development (CVE:CD) Stock Price Up 9.5% – Should You Buy? - Defense World
CEL-SCI (NYSE:CVM) Now Covered by StockNews.com - Defense World
CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer - Yahoo Finance
Pre-market Movers: AVGR, TIVC, ATNF, SLGL... - RTTNews
CVM stock touches 52-week low at $0.37 amid sharp annual decline - Investing.com Nigeria
Hanlon Investment Management Inc. Purchases 405 Shares of Microsoft Co. (NASDAQ:MSFT) - Defense World
CEL-SCI Corporation (NYSE:CVM) Announces Completion of $5 Million OfferingOn December 31, 2024, CEL-SCI Corporation, a Colorado corporation, disclosed the successful closure of an offering valued at approximately $5,000,000. The offering involved t - Defense World
Cel-Sci Stock Slips After Public Offering: Retail's Neutral - MSN
CEL-SCI completes $5 million stock offering - Investing.com
CEL-SCI Announces Closing of $5 Million Offering - Yahoo Finance
8 things to know: Big Lots strikes deal to save hundreds of stores - The Business Journals
CVM Stock Hits 52-Week Low at $0.42 Amid Market Challenges - Investing.com Nigeria
SEC Form 424B5 filed by Cel-Sci Corporation - Quantisnow
Why Vincerx Pharma Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket - Benzinga
5 Stocks To Watch Heading Into Monday - MSN
CCSC Technology International, CEL-SCI And 3 Stocks To Watch Heading Into Monday - Benzinga
CEL-SCI Announces Pricing of $5 Million Public Offering - Yahoo Finance
CEL-SCI Announces $5M Public Offering to Advance FDA-Designated Orphan Drug Multikine Cancer Therapy - StockTitan
CEL-SCI announces proposed public offering of common stock - MSN
CEL-SCI announces common stock offering, no amount given - MSN
CVMCel-Sci Corporation Latest Stock News & Market Updates - StockTitan
CEL-SCI Announces Proposed Public Offering of Common Stock - Yahoo Finance
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Cancer Stocks in the Spotlight: The Immunotherapy Revolution - Baystreet.ca
CEL-SCI (NYSE:CVM) Trading Down 4.4% – Should You Sell? - Defense World
Have a Relaxing Holiday Season - Baystreet.ca
From Crisis to Opportunity: How Advances in Immunotherapy Are Shaping the Oncology Sector - Baystreet.ca
$258 Billion Market: Why Cancer Immunotherapy Is Transforming Both Care and Portfolios - Baystreet.ca
AAR Droops on Linking with GA - Baystreet.ca
Oaktree Specialty Lending (NASDAQ:OCSL) Stock Rating Upgraded by StockNews.com - Defense World
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Stake Boosted by The Manufacturers Life Insurance Company - Defense World
CEL-SCI Highlights Biological Rationale for the Use of Multikine in the Confirmatory Registration Head and Neck Cancer Study - Yahoo Finance
CVM: CRO Selected for Registrational Trial - Research Tree
Cel-Sci stock hits 52-week low at $0.54 amid sharp decline - Investing.com
Cel-Sci Corp (CVM) Stock Behavior Is Not Predictable - Stocks Register
Therapeutic Vaccines Market Size on Track to Surpass USD 140 Billion by 2032 at a 18.2% CAGR | VMR - EIN News
StockNews.com Downgrades CEL-SCI (NYSE:CVM) to Sell - Defense World
1.66%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):